This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1982.
Company Filing History:
Years Active: 1982
Title: Fulberth: Innovator in Hypertonia Treatment
Introduction
Fulberth is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of hypertonia. His innovative approach has led to the development of a unique method that addresses this condition effectively.
Latest Patents
Fulberth holds 1 patent for his invention titled "Method for treating hypertonia." This method involves a preparation of N-(2-furfuryl)-4-chloro-5-sulfamoyl-anthranilic acid, which features a slightly retarded release mechanism. The active substance's release is carefully controlled, ensuring that no more than 5% is released after one hour in a buffer solution of pH 1.5, and about 10 to at most 25% after a two-hour treatment in a buffer solution of pH 5.5.
Career Highlights
Fulberth has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on innovative treatments that can improve patient outcomes in the management of hypertonia.
Collaborations
Throughout his career, Fulberth has collaborated with esteemed colleagues such as Gebhard Dahlhausen and Hans-Werner Dibbern. These partnerships have contributed to the advancement of his research and the successful development of his patented method.
Conclusion
Fulberth's contributions to the treatment of hypertonia exemplify the impact of innovative thinking in medicine. His patented method showcases the potential for advancements in therapeutic approaches, ultimately benefiting patients in need.